Drug Discovery as a Data Problem

Sajith Wickramasekara, Founder and CEO of Benchling, spoke at Data Driven NYC on January 24th, 2017. He discussed how software is utilizing data to produce new, cutting-edge drugs at an increasingly rapid pace.

Data Driven NYC is a monthly event covering Big Data and data-driven products and startups, hosted by Matt Turck, partner at FirstMark Capital.